Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...
 
 

Direct Oral Anticoagulation (DOACs) in Special Populations


Date: Jun 4, 2018 02:30 PM - 03:30 PM

Fee

$0.00

CE Hours

1.00

CE Units

0.100

Registration closes on Jun 04, 2018 10:30 PM

Activity Type

  • Knowledge

Target Audience(s)

  • Pharmacist

Accreditation(s)

Accreditation Council for Pharmacy Education
Accreditation Statement: Howard University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

 

 

Registration Closed  

Objectives

  • Describe the evidence for use of direct oral anticoagulants (DOACs) in cancer, kidney disease, and extreme weight patients.
  • Identify key practical points for managing VTE in cancer, kidney disease, and extreme weight patients.
  • Discuss appropriate care and monitoring plans for these patient populations.

Speaker(s)/Author(s)

Dhakrit Rungkitwattanakul, Pharm.D.
PGY-1 Pharmacy Practice Resident

Activity Number

0010-0000-18-005-L01-P
Date: 06/04/18
Time: 02:30 PM - 03:30 PM

CE Hours

1.00
Registration Closed